CENTER FOR NEUROMETABOLISM
Defining the Neural Control of Metabolism From Molecules to Brain
Defining the Neural Control of Metabolism From Molecules to Brain
We aim to define how the brain interprets and integrates information about the body’s metabolic state, and how these processes become disrupted in conditions such as obesity and type 2 diabetes. By combining expertise across biological scales, we will drive discoveries that will shape new strategies for treating metabolic disease.

Dr. Zhiping Pang (Director, Center for NeuroMetabolism)
Metabolic homeostasis emerges from dynamic, bidirectional communication between the brain and the body. Distributed neural circuits coordinate behaviors and physiological responses that regulate energy balance, while hormonal and nutrient signals from the periphery feed back to the brain to adjust circuit activity and maintain stability.
Dysregulation of these pathways contributes not only to metabolic disorders, but also to a broad range of neurological and neuropsychiatric conditions, where disrupted brain–body signaling affects circuit function, behavior, and disease progression. Our research bridges these domains by translating mechanistic insights into therapeutic strategies for both metabolic and brain disorders.

Our labs combine advanced approaches, including deep-brain imaging, electrophysiology, behavior, whole-body metabolism, gene editing, and single-cell and spatial transcriptomics, to map neural circuits and molecular signals that govern metabolic health.

We seek to advance understanding of the bidirectional relationships between brain function and metabolism, and to lead the next generation of discoveries that will inform innovative strategies for treating metabolic disease.

The Pang Lab studies how neuropeptides regulate synaptic function and neural circuits that control metabolism. For more than a decade, the lab has focused on central GLP-1 signaling and its role in linking neuroendocrine signals to synaptic plasticity, feeding behavior, and energy homeostasis. Through work published in journals such as Neuron and Nature Metabolism, the lab has identified key brain circuits and cellular mechanisms through which GLP-1 signaling regulates appetite and metabolic balance. These discoveries provide important insights into how GLP-1–based therapies act in the brain and suggest new strategies to improve treatments for obesity and metabolic disease.

The Rossi Lab studies how distributed neural circuits regulate feeding and motivated behavior, and how these processes are disrupted by external factors such as diet. The lab is particularly interested in how early-life nutrition shapes neural circuit function and behavior later in life. Using deep-brain two-photon calcium imaging, electrophysiology, and viral-based genetic tools, the lab measures and manipulates neural activity during motivated behaviors. These approaches allow the lab to track how neuronal activity changes during feeding, reward processing, and the development of diet-induced obesity.
Published in Nature Metabolism, this study reveals how GLP-1—the same hormone targeted by widely used weight-loss drugs such as Ozempic—acts in the brain to regulate food intake. Researchers at the CNM identified a specific neural circuit connecting the hypothalamus and brainstem that is strengthened by GLP-1 signaling and, when activated, suppresses feeding. Notably, this circuit dynamically adapts to internal state, responding more strongly to GLP-1 during hunger than satiety. In obesity, however, this flexibility is impaired, providing new insight into how GLP-1–based therapies act on the brain and why their effects may vary across metabolic states.
Published in Nature Communications, researchers at the CNM identified a neural circuit linking the extended amygdala to the lateral hypothalamus that adjusts reward-seeking behavior based on energy state. The pathway becomes more active during hunger, increasing motivation for food, and less responsive during satiety. This circuit shows dynamic plasticity, tuning behavior to match metabolic needs. Disruption of this plasticity may contribute to overeating and broader disorders involving reward and motivation.
In the News: Two Rutgers Teams Trace Brain Circuits That Tell Us When to Eat – and When to Stop
Published in Molecular Metabolism, researchers at the center show that GLP-1 receptor–expressing neurons in the dorsolateral septum project to the lateral hypothalamus, forming an inhibitory circuit that suppresses food intake. Manipulating this pathway directly alters feeding behavior. This study highlights a previously underappreciated brain pathway and identifies new potential targets for treating obesity and eating disorders.
Published in Bioscience Reports, this study reveals that viral vector–mediated toxicity in the paraventricular hypothalamic nucleus (PVN) can lead to significant metabolic and behavioral disturbances. The researchers at the CNM show that unintended neuronal damage in this key regulatory hub disrupts energy balance and alters feeding-related behaviors. These findings highlight an important technical and biological consideration when using viral tools to manipulate hypothalamic circuits.
Published in Molecular Metabolism, researchers at the CNM reveal that maternal overnutrition rewires feeding circuits in the developing brain. By altering synaptic input to the lateral hypothalamic area, early-life nutritional excess programs long-term changes in energy balance and increases susceptibility to obesity.
Child Health Institute of NJ & Zoom
We invite you to attend a special seminar by Dr. Lin Mei, distinguished investigator at the Chinese Institutes for Medical Research and Chai...
Child Health Institute of NJ & Zoom
San Diego, California
CNM researchers had a strong presence at the Society for Neuroscience 2025 in San Diego, showcasing their latest research findings.
San Diego, California
Child Health Institute of NJ & Zoom
We invite you to attend a special seminar by Dr. Anders Nelson, Assistant Professor of Neural Science at New York University, whose research...
Child Health Institute of NJ & Zoom
The Center for NeuroMetabolism was established with the founding labs of Drs. Pang and Rossi, bringing together over 25 trainees to advance ...
The Center for NeuroMetabolism is currently recruiting researchers at all career stages as we prepare to relocate to the new HELIX NJ complex in summer 2026.
Tenure-track or tenured faculty positions at the Assistant, Associate, or Full Professor level.
Address: 89 French Street, New Brunswick, NJ 08901, USA
Phone: (732)-235-8074
Copyright © 2026 NeuroMetabolism - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.